2023 - Research.com Best Scientist Award
2023 - Research.com Medicine in Germany Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in Germany Leader Award
His Organic chemistry research incorporates elements of Catalysis and Combinatorial chemistry. His work blends Combinatorial chemistry and Organic chemistry studies together. Combining a variety of fields, including Ulcerative colitis, Pouchitis and Vedolizumab, are what the author presents in his essays. He integrates several fields in his works, including Pouchitis and Ulcerative colitis. His study in Internal medicine intersects with areas of studies such as Gastroenterology and Surgery. In his research, he undertakes multidisciplinary study on Gastroenterology and Internal medicine. In his papers, he integrates diverse fields, such as Surgery and Disease. His Disease study frequently links to related topics such as Vedolizumab. Many of his studies involve connections with topics such as Information retrieval and Schema (genetic algorithms).
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Stephen B Hanauer;Brian G Feagan;Gary R Lichtenstein;Lloyd F Mayer.
The Lancet (2002)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins;Stephan Ripke;Rinse K Weersma;Richard H Duerr.
Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg;Jack Satsangi;Tariq Ahmad;Ian D. R. Arnott.
Canadian Journal of Gastroenterology & Hepatology (2005)
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
Elizabeth K. Speliotes;Elizabeth K. Speliotes;Cristen J. Willer;Sonja I. Berndt;Keri L. Monda.
Nature Genetics (2010)
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Andre Franke;Dermot P B McGovern;Jeffrey C. Barrett;Kai Wang.
Nature Genetics (2010)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer.
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Jean–Frédéric Colombel;William J. Sandborn;Paul Rutgeerts;Robert Enns.
Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study
Benjamin F. Voight;Benjamin F. Voight;Benjamin F. Voight;Gina M. Peloso;Gina M. Peloso;Marju Orho-Melander;Ruth Frikke-Schmidt.
web science (2012)
Hundreds of variants clustered in genomic loci and biological pathways affect human height
Hana Lango Allen;Karol Estrada;Guillaume Lettre;Sonja I. Berndt.
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1
Jochen Hampe;Andre Franke;Philip Rosenstiel;Philip Rosenstiel;Andreas Till.
Nature Genetics (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: